Mesalamine Tablet, Delayed Release
Product Images NDC 63304-175

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 63304-175). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl Mesalamine Label1

Each delayed-release tablet contains 1.2g mesalamine, USP. Refer to package insert for dosage information. The tablets are child-resistant and should be stored between 20°C to 25°C. They come in a tight, light-resistant container and should be dispensed by a pharmacist. This product is distributed by Sun Pharmaceutical Industries, Inc. and manufactured by Sun Pharmaceutical Industries Limited in India. Available in 120 tablets per Rx only.*

FDA Label Image

Spl Mesalamine Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.